Stockreport

Minimal Residual Disease Market to Hit USD 2.55 Billion by 2029 with 12.2% CAGR | MarketsandMarkets™ [Yahoo! Finance]

Guardant Health, Inc.  (GH) 
Last guardant health, inc. earnings: 2/24 04:03 pm Check Earnings Report
PDF Factors that fuel the growth of the minimal residual disease testing market in terms of geography include the increasing incidence of cancer and hematological malignanci [Read more]